 - To determine the rate of neutrophil engraftment and grade III-IV acute graft-versus-host disease GVHD following a T cell depleted TCD umbilical cord blood UCB transplantation without post-transplant immunosuppression followed by administration of interleukin-2 IL-2, aldesleukin every other day days 3 to 13 to expand NK cells in vivo. 